AusPAR: Vandetanib

Australian Public Assessment Report

AusPAR

AusPAR: Vandetanib [PDF, 1.16 MB]

AusPAR: Vandetanib [Word, 1.52 MB]

Attachment: Product Information: Vandetanib [PDF, 184.58 KB]

Attachment: Product Information: Vandetanib [Word, 64.89 KB]

Attachment: Extract from Clinical Evaluation Report: Vandetanib [PDF, 3.23 MB]

Attachment: Extract from Clinical Evaluation Report: Vandetanib [Word, 5.78 MB]

Device/Product Name

Caprelsa

Active ingredients

Vandetanib

AusPAR Date

7 August 2013

Published

17 September 2013

Submission Number

PM-2011-03002-3-4

Submission Type

New chemical entity

Decision

Approved